To determine if the EGFR kinase activity is essential for EREG-induced PDL1, we examined the roles of EREG in absence or presence of EGFR inhibitors, erlotinib, gefitinib, or AG1478 in HNSCC cells. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.